Charta Health Raises $55M in Series B Funding led by Insight Partners

Charta Health, a San Francisco, CA-based provider of an AI medical chart review platform built for billing accuracy, has raised $55 million in a Series B funding round.

The round was led by Insight Partners with participation from Madrona, Bain Capital Ventures, South Park Commons, and QuantumLight.

The company will use the funding to accelerate AI research and development and launch its products for healthcare providers and insurance companies.

What is Charta Health?

Charta Health develops AI software that reviews medical records to help ensure healthcare claims are accurately coded and supported by clinical documentation.

Read More:Synctera Raises $24.5M to Support Banking Platform Growth

Its platform analyses patient records to identify missing codes supported by the documentation and flag codes that are not adequately justified. This helps healthcare providers submit more accurate claims and reduces the risk of denials, appeals and payment clawbacks.

The company serves healthcare providers and health insurance companies. Its technology is designed to give both sides a shared standard for reviewing medical records before claims are submitted.

Charta aims to reduce disagreements between providers and insurers, which can lead to costly claim denials and appeals. A 2025 study estimated that claims adjudication cost US hospitals and health systems more than $25 billion in 2023, with nearly $18 billion potentially wasted on denials and appeals.

How Much Funding Has Charta Health Raised?

Charta Health has raised $55 million in its Series B round. The company has raised three funding rounds in less than two years, although the announcement did not disclose its total funding or the amounts and dates of previous rounds.

Who Invested in Charta Healths Series B?

Insight Partners led the $55 million Series B round.

Other participating investors include:

• Madrona
• Bain Capital Ventures
• South Park Commons
• QuantumLigh

Why the Funding Matters

Charta Health will use the investment to accelerate its AI research and development and expand its products for healthcare providers and insurance companies.

The funding will support the launch of Charta for Providers and Charta for Payers. The company aims to make its AI review technology available across both sides of the healthcare payment process.

The latest funding announcement also coincides with the launch of Charta for Payers, a product suite developed for health plans in partnership with one of the largest health insurers in the US.

Who founded Charta Health?

Charta Health was founded by Justin Liu and Scott Morris. The company is headquartered in San Francisco, California. The announcement did not specify its founding year.

"We came to healthcare as engineers and saw a system where the most important data was locked in documents no one had time to read," said Justin Liu, CEO and co-founder of Charta Health. "Charta unlocks that data. When every chart gets reviewed, accuracy stops being a guess. Payers and providers should agree on the chart before a claim goes out, not fight about it after.

Market and Business Growth

Charta Health reported that its revenue grew 10 times over the past 12 months. The company has also raised three funding rounds in less than two years.

Its customers include major healthcare organisations such as American Family Care, Grow Therapy, and Pediatric Associates Family of Companies.

Charta for Providers reviews medical records before claims are submitted. It checks documentation against coding guidelines, payer rules and each organisation's clinical protocols. Its findings are presented for human approval within the electronic health record system.

What Happens Next?

Charta Health plans to invest in AI research and development while expanding its services for healthcare providers and insurers.

The company will focus on launching Charta for Providers and Charta for Payers, with the goal of improving medical chart reviews, supporting accurate billing and reducing unnecessary claim disputes.

Read More:Nyquis Raises $6.3M Seed Funding for Grid Monitoring